1. Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
2. Medivation
10K, for year ending Dec 31, 2014. http://www.annualreports.com/HostedData/AnnualReportArchive/m/NASDAQ_MDVN_2014.pdf (accessed December 20, 2019).
3. aSawyers, C. L.; Jung, M. E.; Chen, C. D.; Ouk, S.; Welsbie, D.; Tran, C.; Wongvipat, J.; Yoo, D. Diarylhydantoin Compounds. PCT Int. Patent Appl. WO 2006/124118, November 23, 2006.
4. bSawyers, C. L.; Jung, M. E.; Chen, C. D.; Ouk, S.; Welsbie, D.; Tran, C.; Wongvipat, J.; Yoo, D. Diarylhydantoin Compounds. U.S. Patent 7709517 B2, May 4, 2010.
5. cJung, M. E.; Yoo, D.; Sawyers, C. L.; Tran, C.; Wongvipat, J. Diarylhydantoin Compounds. U.S. Patent 8110594 B2, February 7, 2012.